These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17204410)

  • 1. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
    Janssens S; de Armas HN; Remon JP; Van den Mooter G
    Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions.
    Janssens S; Anné M; Rombaut P; Van den Mooter G
    Eur J Pharm Sci; 2009 Jun; 37(3-4):241-8. PubMed ID: 19491011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
    Van den Mooter G; Weuts I; De Ridder T; Blaton N
    Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
    Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.
    Janssens S; de Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1114-20. PubMed ID: 18502629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution enhancement of itraconazole by hot-melt extrusion alone and the combination of hot-melt extrusion and rapid freezing--effect of formulation and processing variables.
    Lang B; McGinity JW; Williams RO
    Mol Pharm; 2014 Jan; 11(1):186-96. PubMed ID: 24283890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.
    Janssens S; De Zeure A; Paudel A; Van Humbeeck J; Rombaut P; Van den Mooter G
    Pharm Res; 2010 May; 27(5):775-85. PubMed ID: 20195707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers.
    Six K; Verreck G; Peeters J; Brewster M; Van Den Mooter G
    J Pharm Sci; 2004 Jan; 93(1):124-31. PubMed ID: 14648642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
    Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
    AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.
    Janssens S; Roberts C; Smith EF; Van den Mooter G
    Int J Pharm; 2008 May; 355(1-2):100-7. PubMed ID: 18191508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology evaluation: Kollicoat IR.
    Fouad EA; El-Badry M; Neau SH; Alanazi FK; Alsarra IA
    Expert Opin Drug Deliv; 2011 May; 8(5):693-703. PubMed ID: 21417781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
    Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.
    Bhardwaj V; Trasi NS; Zemlyanov DY; Taylor LS
    Int J Pharm; 2018 Apr; 540(1-2):106-119. PubMed ID: 29425762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.